Trim BKNG to 0.65-0.70x benchmark weight on hostile technicals and escalating macro
Underweight BKNG at 0.65-0.70x benchmark weight. The valuation case (forward P/E 14×, PEG 0.71, fortress balance sheet with $17.2B cash vs $1.5B net debt, 5.9% FCF yield, 7%+ total shareholder yield) is compelling but secondary to the prior decision fingerprint. Hold bleeds alpha (-2.5% average) while Underweight captures modest alpha (-1.3% net) on this name in this regime. Execute trim on relief bounces toward $185-190, not into capitulation. Hard stop at $148. Re-engagement triggers clearly defined: close above $208 on volume >7M with MACD positive, or Q3 earnings beat-and-raise.
| Position | Action |
|---|---|
| Current weight to 0.65-0.70x | Trim 30-35% from current position over 1-3 sessions |
| Confirmed close below $170 on volume >9M shares | Trim further to 0.50-0.55x |
| Confirmed close below $160 on heavy volume | Full exit - structural breakdown thesis |
| Confirmed close below $185 on volume >8M shares | Trim to 0.50-0.55x |
| Confirmed close below $175 with MACD still expanding negative | Trim to 0.40-0.45x |
| $160 breaks on heavy volume | Exit to flat |
A high-quality compounder being indiscriminately sold at 14x forward P/E with 0.71 PEG while fundamentals are at record levels and management is aggressively buying back stock.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | 192.58 | bearish |
| 50 SMA | 194.05 | bearish |
| 200 SMA | 185.23 | bearish |
| RSI | 29.19 | neutral |
| MACD | -3.31 | bearish |
| MACD Signal | 1.12 | bearish |
| MACD Histogram | -4.43 | bearish |
| Bollinger Middle (20 SMA) | 203.20 | bearish |
| Bollinger Upper | 225.61 | neutral |
| Bollinger Lower | 180.78 | bearish |
| ATR | 7.15 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Successful back-and-fill of 200 SMA from below (5-10 sessions of sideways action on declining volume)
Then: Re-engage toward Hold/Overweight
EV: +40–60% over 12–18 months · concedes: MACD histogram at −4.43 and expanding is the most concerning technical signal; Distribution volume is real and capitulation volume does clear weak hands; Company is issuing new debt ($1.98B in Q2 2026) to fund buybacks rather than using cash reserves; FCF yield of ~5.9% and 7%+ total shareholder yield suggest a value trap rather than growth opportunity if macro deterioration continues
BKNG's bull case is structurally flawed due to hidden revenue deceleration (Q2 2026 growth halved to +8.2% from 13.4% in 2025), misleading "cheap" valuation on forward EPS likely 10-15% too high, moat erosion from AI channel disintermediation, and levered capital destruction via debt-funded buybacks ($1.98B new Q2 2026 debt issuance).
· concedes: Bull's revenue print of $7.35B is accurate; EBITDA margins of 41% are accurate; Capital return yield of 7% is accurate; RSI at 29 is technically accurate; Chart showing decline is accurate; The bull put together a clean pitch; The $17.2B cash position is real; The $9.4B annual OCF is real; The $4.31B quarterly capital return is real; Will flip to neutral if (1) 10 EMA reclaim at $192.58 on heavy volume with MACD histogram contracting AND (2) bullish RSI divergence; Will flip to bullish if above conditions met plus Iran ceasefire crashes oil to $80s and pulls 10-year yields down 20bps+
→ vs conservative: Conservative's technical-only analysis misses fundamental picture — 5 of 6 bearish signals are a symptom of macro indiscriminate selling, not fundamental deterioration; waiting for 10 EMA reclaim at 192.58 means paying 11% more for confirmation
→ vs neutral: Neutral conflating high-quality compounder with cyclically challenged name — 34.4% operating margins, 20.4% ROA, 50% FCF margin, fortress balance sheet contradicts cyclical weakness narrative
→ vs neutral: Neutral's macro concerns already priced in — hawkish Fed, oil shock, geopolitical risk fully reflected in 22% drawdown; no incremental risk remains
→ vs conservative: Conservative's stop-loss at 148 with 15.7% risk exposure justified by multiples of upside and franchise quality that makes 148 breakdown unlikely
| neutral |
| VWMA | 196.97 | bearish |
| Volume (2026-09-08) | 10,892,400 | neutral |
| Volume (2026-09-09) | 11,991,504 | neutral |
Support: 185.23 · 180.78 · 173.43 · 170.12 | Resistance: 225.61 · 214.42 · 203.2 · 199 · 200 · 194.05 · 192.58
BKNG is in a sharp downtrend with price at $173.43, down approximately 22.9% from the August 7 high of $214.42. The stock trades below all moving averages (10 EMA at 192.58, 50 SMA at 194.05, 200 SMA at 185.23) and has broken below the lower Bollinger Band at $180.78, indicating capitulation. Momentum is decisively bearish with MACD at −3.31, histogram at −4.43 and expanding, while RSI at 29.19 is deeply oversold but lacks reversal confirmation. Key support sits at $170.12 (September 9 intraday low) with resistance overhead at $192.58 (10 EMA) and $194.05 (50 SMA).
Market Cap
$130.3B
Enterprise Value
~$132B
P/E (TTM)
19.27x
Forward P/E
14.01x
PEG Ratio
0.71
P/B
-12.19x
Dividend Yield
0.93%
EPS (TTM)
$9.00
Forward EPS
$12.38
Beta
1.07
52-Week High
$224.99
52-Week Low
$150.14
50-Day MA
$194.23
200-Day MA
$185.78
Revenue (2025)
$26,917M
Operating Income (2025)
$9,282M
Operating Margin
34.5%
EBITDA (2025)
$9,217M
Net Income (2025)
$5,404M
Diluted EPS (2025)
$6.62
Revenue Growth (4-Yr CAGR)
~16.3%
Operating Income Growth (4-Yr CAGR)
~22.0%
Net Income Growth (4-Yr CAGR)
~21.0%
EPS Growth (4-Yr CAGR)
~29.4%
Operating Cash Flow (2025)
$9,409M
Free Cash Flow (2025)
$9,087M
CapEx (2025)
$322M
CapEx as % of Revenue
~1.2%
Share Repurchases (2025)
$6,440M
Dividends (2025)
$1,248M
Cash & Equivalents (FY2025)
$17,203M
Total Debt (FY2025)
$19,293M
Net Debt (FY2025)
$1,533M
Net Debt / EBITDA
~0.3x
Total Assets (FY2025)
$29,264M
Stockholders' Equity (FY2025)
-$5,578M
Treasury Stock (FY2025)
$54,315M
Working Capital (FY2025)
$5,566M
Current Ratio
1.09
Interest Coverage
~5.2x
ROA
20.4%
Profit Margin
25.5%
FCF Margin (TTM)
~27.4%
Q2 2026 Revenue
$7,352M
Q2 2026 Net Income
$1,950M
Q2 2026 Diluted EPS
$2.53
Q2 2026 FCF
$3.64B
Q2 2026 Buybacks
$3.99B
Q2 2026 Cash
$17,214M
Q2 2026 Total Debt
$20,694M
Q2 2026 Treasury Stock
$62,129M
Q2 2026 Stockholders' Equity
-$10,783M
Diluted Share Count (Q2 2026)
770M
Revenue TTM
$28.24B
Gross Profit TTM
$24.63B
EBITDA TTM
$10.41B
Net Income TTM
$7.21B
FCF TTM
$7.73B
Deferred Revenue (FY2025)
$5.27B
Deferred Revenue (Q2 2026)
$10.12B
2026E EPS
$165–$170
Strengths
Concerns
HOLD
Macro: Risk-off and inflationary backdrop characterized by Brent crude crossing $101/barrel amid escalating Iran conflict, Treasury Secretary Bessent tripling the buyback program size to $6bn yet yields still rising, and equity selloff (Dow -400 points) driven by geopolitics and AI-software selling. Fed remains hawkish with 93% probability of no cuts in 2026 (up +4pp week-over-week), while recession odds stay muted at only 8%, suggesting the selloff reflects inflation/geopolitical fears rather than growth deterioration. Israel–Iran ceasefire holds through Sep 30 at 86% but only 64% through year-end, presenting meaningful tail risk for oil stability.